Predictive Oncology Inc (NASDAQ:POAI) shares are trading higher by 46.6% to $2.30 during Tuesday’s session after the company announced positive results from a retrospective study conducted with UPMC Magee-Womens Hospital.
These results will be presented at the 2024 ASCO Annual Meeting in Chicago. The study aimed to develop machine learning (ML) models to predict short-term (two-year) and long-term (five-year) survival outcomes in ovarian cancer patients. Per the company, high grade serous ovarian cancer is challenging to treat, with high relapse rates and low long-term survival.
The ML models showed promise in improving patient prognosis predictions, potentially aiding clinical management and personalized treatment plans. Predictive Oncology emphasized the potential of AI and ML in enhancing oncology drug discovery and clinical management, highlighting ...
POAI) Stock Is Skyrocketing>Full story available on Benzinga.com